Ardian to take majority stake in Italian drug maker Neopharmed Gentili

Ardian has agreed to acquire a majority stake in Neopharmed Gentili, an Italian drug maker. No financial terms were disclosed. Mediolanum Farmaceutici will retain a minority stake in in Neopharmed Gentili. In addition to the transaction, Alessandro Del Bono will become chairman and CEO of the company.

DealsNorth AmericaUSHealthcareBriefs